AAAAAA
Results:
1-21
|
Results: 21
Authors:
BOUCK N
CAMPBELL S
Citation: N. Bouck et S. Campbell, ANTICANCER DIVIDENDS FROM CAPTOPRIL AND OTHER INHIBITORS OF ANGIOGENESIS, JN. Journal of nephrology, 11(1), 1998, pp. 3-4
Authors:
VOGLER WR
LIU JG
VOLPERT O
ADES EW
BOUCK N
Citation: Wr. Vogler et al., THE ANTICANCER DRUG EDELFOSINE IS A POTENT INHIBITOR OF NEOVASCULARIZATION IN-VIVO, Cancer investigation, 16(8), 1998, pp. 549-553
Authors:
CRAWFORD SE
STELLMACH V
MURPHYULLRICH JE
RIBEIRO SMF
LAWLER J
HYNES RO
BOIVIN GP
BOUCK N
Citation: Se. Crawford et al., THROMBOSPONDIN-1 IS A MAJOR ACTIVATOR OF TGF-BETA-1 IN-VIVO, Cell, 93(7), 1998, pp. 1159-1170
SEQUENTIAL DEVELOPMENT OF AN ANGIOGENIC PHENOTYPE BY HUMAN FIBROBLASTS PROGRESSING TO TUMORIGENICITY
Authors:
VOLPERT OV
DAMERON KM
BOUCK N
Citation: Ov. Volpert et al., SEQUENTIAL DEVELOPMENT OF AN ANGIOGENIC PHENOTYPE BY HUMAN FIBROBLASTS PROGRESSING TO TUMORIGENICITY, Oncogene, 14(12), 1997, pp. 1495-1502
Authors:
BOUCK N
Citation: N. Bouck, CONTROL OF INHIBITORS OF ANGIOGENESIS BY TUMOR-SUPPRESSOR GENES, The FASEB journal, 11(9), 1997, pp. 3470-3470
THE MECHANISM OF CANCER-MEDIATED CONVERSION OF PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR ANGIOSTATIN
Authors:
GATELY S
TWARDOWSKI P
STACK MS
CUNDIFF DL
GRELLA D
CASTELLINO FJ
ENGHILD J
KWAAN HC
LEE F
KRAMER RA
VOLPERT O
BOUCK N
SOFF GA
Citation: S. Gately et al., THE MECHANISM OF CANCER-MEDIATED CONVERSION OF PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR ANGIOSTATIN, Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 10868-10872
Authors:
TOLSMA SS
STACK MS
BOUCK N
Citation: Ss. Tolsma et al., LUMEN FORMATION AND OTHER ANGIOGENIC ACTIVITIES OF CULTURED CAPILLARYENDOTHELIAL-CELLS ARE INHIBITED BY THROMBOSPONDIN-1, Microvascular research, 54(1), 1997, pp. 13-26
Authors:
STELLMACH V
VOLPERT OV
CRAWFORD SE
LAWLER J
HYNES RO
BOUCK N
Citation: V. Stellmach et al., TUMOR-SUPPRESSOR GENES AND ANGIOGENESIS - THE ROLE OF TP53 IN FIBROBLASTS, European journal of cancer, 32A(14), 1996, pp. 2394-2400
Authors:
PORRAS A
BENNETT J
HOWE A
TOKOS K
BOUCK N
HENGLEIN B
SATHYAMANGALAM S
THIMMAPAYA B
RUNDELL K
Citation: A. Porras et al., A NOVEL SIMIAN-VIRUS-40 EARLY-REGION DOMAIN MEDIATES TRANSACTIVATION OF THE CYCLIN A PROMOTER BY SMALL-T ANTIGEN AND IS REQUIRED FOR TRANSFORMATION IN SMALL-T ANTIGEN-DEPENDENT ASSAYS, Journal of virology, 70(10), 1996, pp. 6902-6908
Authors:
VOLPERT O
JACKSON D
BOUCK N
LINZER DIH
Citation: O. Volpert et al., THE INSULIN-LIKE GROWTH-FACTOR II MANNOSE 6-PHOSPHATE RECEPTOR IS REQUIRED FOR PROLIFERIN-INDUCED ANGIOGENESIS/, Endocrinology, 137(9), 1996, pp. 3871-3876
Authors:
GATELY S
TWARDOWSKI P
STACK MS
PATRICK M
BOGGIO L
CUNDIFF DL
SCHNAPER HW
MADISON L
VOLPERT O
BOUCK N
ENGHILD J
KWAAN HC
SOFF GA
Citation: S. Gately et al., HUMAN PROSTATE CARCINOMA-CELLS EXPRESS ENZYMATIC-ACTIVITY THAT CONVERTS HUMAN PLASMINOGEN TO THE ANGIOGENESIS INHIBITOR, ANGIOSTATIN, Cancer research, 56(21), 1996, pp. 4887-4890
Authors:
VOLPERT OV
STELLMACH V
BOUCK N
Citation: Ov. Volpert et al., THE MODULATION OF THROMBOSPONDIN AND OTHER NATURALLY-OCCURRING INHIBITORS OF ANGIOGENESIS DURING TUMOR PROGRESSION, Breast cancer research and treatment, 36(2), 1995, pp. 119-126
Authors:
VOLPERT OV
TOLSMA SS
PELLERIN S
FEIGE JJ
CHEN H
MOSHER DF
BOUCK N
Citation: Ov. Volpert et al., INHIBITION OF ANGIOGENESIS BY THROMBOSPONDIN-2, Biochemical and biophysical research communications, 217(1), 1995, pp. 326-332
Authors:
DAMERON KM
VOLPERT OV
BOUCK N
Citation: Km. Dameron et al., REGULATION OF AN ANGIOGENESIS INHIBITOR IN HUMAN FIBROBLASTS BY THE P53 TUMOR-SUPPRESSOR GENE, Journal of cellular biochemistry, 1994, pp. 187-187
Authors:
TOLSMA SS
VOLPERT O
BOUCK N
Citation: Ss. Tolsma et al., TSP-1 AND ITS PEPTIDES BLOCK ANGIOGENESIS BY MAKING ENDOTHELIAL-CELLSREFRACTORY TO STIMULI AND BY ENHANCING DIFFERENTIATION, Journal of cellular biochemistry, 1994, pp. 335-335
Authors:
DAMERON KM
VOLPERT OV
TAINSKY MA
BOUCK N
Citation: Km. Dameron et al., THE P53 TUMOR-SUPPRESSOR GENE INHIBITS ANGIOGENESIS BY STIMULATING THE PRODUCTION OF THROMBOSPONDIN, Cold Spring Harbor Symposia on Quantitative Biology, 59, 1994, pp. 483-489
Authors:
JACKSON D
VOLPERT OV
BOUCK N
LINZER DIH
Citation: D. Jackson et al., STIMULATION AND INHIBITION OF ANGIOGENESIS BY PLACENTAL PROLIFERIN AND PROLIFERIN-RELATED PROTEIN, Science, 266(5190), 1994, pp. 1581-1584
Authors:
DAMERON KM
VOLPERT OV
TAINSKY MA
BOUCK N
Citation: Km. Dameron et al., CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1, Science, 265(5178), 1994, pp. 1582-1584
Authors:
LINGEN M
POLVERINI P
BOUCK N
Citation: M. Lingen et al., THE ANTIANGIOGENIC EFFECTS OF RETINOIC ACID IN ORAL SQUAMOUS-CELL CARCINOMA, Journal of dental research, 73, 1994, pp. 360-360
Authors:
JOHNSON MD
KIM HRC
CHESLER L
TSAOWU G
BOUCK N
POLVERINI PJ
Citation: Md. Johnson et al., INHIBITION OF ANGIOGENESIS BY TISSUE INHIBITOR OF METALLOPROTEINASE, Journal of cellular physiology, 160(1), 1994, pp. 194-202
Authors:
TOLSMA SS
VOLPERT OV
GOOD DJ
FRAZIER WA
POLVERINI PJ
BOUCK N
Citation: Ss. Tolsma et al., PEPTIDES DERIVED FROM 2 SEPARATE DOMAINS OF THE MATRIX PROTEIN THROMBOSPONDIN-1 HAVE ANTI-ANGIOGENIC ACTIVITY, The Journal of cell biology, 122(2), 1993, pp. 497-511
Risultati:
1-21
|